Haw Par (SGX:H02) FFO


SGX:H02 Haw Par Corp Ltd SGX:H02
93 GF Score
Price S$15.93
GF Value S$11.82
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Haw Par FFO?

FFO (Funds from operations) only applies to REITs.

SGX:H02
93GF Score
Haw Par Corp Ltd SGX:H02
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Haw Par (SGX:H02) Overvalued in 2026?

Based on GuruFocus' analysis, Haw Par stock appears to be overvalued. The current stock price of S$15.93 is trading 34.8% above its estimated GF Value™ of S$11.82. GuruFocus considers Haw Par to be Significantly Overvalued.

Key valuation signals for SGX:H02:

  • FFO:
  • GF Value™: S$11.82 vs. price of S$15.93 (34.8% above fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the SGX:H02 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haw Par Business Description

Other Exchanges H4V:Germany
Address 401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
93GF Score

Get the complete analysis for SGX:H02

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$15.93
Price
S$11.82
GF Value